Seeing Is Believing
Currently out of the existing stock ratings of Laura Chico, 221 are a BUY (67.58%), 103 are a HOLD (31.5%), 3 are a SELL (0.92%).
Analyst Laura Chico, currently employed at WEDBUSH, carries an average stock price target met ratio of 47.53% that have a potential upside of 35.94% achieved within 171 days.
Laura Chico’s has documented 662 price targets and ratings displayed on 42 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BIIB, Biogen at 12-Jun-2025.
Analyst best performing recommendations are on DNTH (DIANTHUS THERAPEUTICS).
The best stock recommendation documented was for DNLI (DENALI THERAPEUTICS) at 11/10/2020. The price target of $64 was fulfilled within 1 day with a profit of $4 (6.67%) receiving and performance score of 66.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$1.5
$0.84 (127.27%)
$10
1 years 9 months 23 days ago
(01-Sep-2023)
0/3 (0%)
$0.36 (31.58%)
Buy
$8
$7.34 (1112.12%)
$9
3 years 3 months 17 days ago
(07-Mar-2022)
0/2 (0%)
$5.54 (225.20%)
Buy
$8
$7.34 (1112.12%)
$48
5 years 11 months 30 days ago
(25-Jun-2019)
0/4 (0%)
$3.88 (94.17%)
Which stock is Laura Chico is most bullish on?
Which stock is Laura Chico is most reserved on?
What Year was the first public recommendation made by Laura Chico?